Your AI-Trained Oncology Knowledge Connection!


Video

Dr. Arend Discusses MSI Testing in Gynecologic Malignancies

Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses microsatellite instability testing in patients with gynecologic malignancies.

Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses microsatellite instability (MSI) testing in patients with gynecologic malignancies.

Arend says all of her patients with gynecologic malignancies undergo MSI testing at their first recurrence.

When trials come along that these patients are eligible for, she can then recommend them accordingly.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Syed Abbas Ali, MBBS, an assistant professor of oncology at Johns Hopkins School of Medicine and Sidney Kimmel Comprehensive Cancer Center
Oleg Gluz, MD, chief physician, Breast Cancer Niederrhein
R. Lor Randall, MD, FACS
Dr Zonder on the Need for Increased Awareness in Multiple Myeloma
Shilpa Gupta, MD, director of Genitourinary Medical Oncology at the Taussig Cancer Institute and co-leader of the Genitourinary Oncology Program in the Department of Hematology and Medical Oncology, Cleveland Clinic; as well as a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center
Hyun-Woong Cho, MD, PhD, Department of Obstetrics and Gynecology, Korea University College of Medicine
SHAH
Timothy S. Fenske, MD, MS
Sheela Rao, MBBS, MD, FRCP